Formation of a novel class of F3-isoprostanes during peroxidation of eicosapentaenoic acid (EPA)

Advances in Experimental Medicine and Biology

Volumn 433, Issue , 1997, Pages 185-188

  Nourooz Zadeh, Jaffar ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ICOSAPENTAENOIC ACID; PROSTAGLANDIN F2 ALPHA DERIVATIVE;

ARACHIDONIC ACID METABOLISM; ARTICLE; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; REACTION ANALYSIS;

EID: 0031391233     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-1810-9_38     Document Type: Article

References (10)

1. Harats, D., Dabach, Y., Hollander, G., Ben-Naim, M., Schwartz, R., Berry, E.M., Stein, O., and Stein, Y., Fish oil ingestion in smokers and nonsmoskers enhances peroxidation of plasma lipoproteins, Atheroscler. 90:127 (1991).
2. Lussier-Cancan, S., Dubreuil-Quidoz, S., Roederer, G., Leboeuf, N., Boulet, L., de Langavant, G.C., Davignon, J., and Naruszewicz, M., Influence of probucol on enhanced LDL oxidation after fish oil treatment of hypertriglyceridemic patients, Atheroscler. Thromb. 13:1790 (1993).
3. Oostenbrug, G.S., Mensink, R.P., and Monstra, G., Effect of fish oil and vitamin E supplementation on copper catalysed oxidation of human LDL in vitro, Eur. J. Clin. Nutr. 48:895 (1994).
4. Suzukawa, M, Abbey, M, Howe, P.R.C., Nestel, P.J., Effects of fish oil fatty acids on LDL size, oxidizability, and uptake by macrophages, J. Lipid Res. 36:473 (1995).
5. Steinberg, D., Parthasarathy, S., Carew, T.E., Khoo, J.C., and Witztum, J.L., Beyond cholesterol: modification of LDL that increases its atherogenicity, New Engl. J. Med. 320:915 (1989).
6. Halliwell, B., Oxidative stress, nutrition and health: experimental strategies for optimization of nutritional antioxidant intake in humans, Free Radical. Res. 25:57 (1996).
7. 2-like compounds are produces in vivo in humans by a non-cyclooxgenase, free radical-catalyzed mechanism, Proc. Natl. Acad. Sci. USA 87:9383 (1990).
8. Morrow J.D., Roberts II, J.L., The isoprostanes: current knowledge and directions for future research, Biochem. Pharmcol. 51:1 (1996).
9. 2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by GC-MS: develoment of a solid phase extraction procedure, J. Chromatogr. Biomed. Appl. 667:199 (1995).
10. 2α levels are elevated in individuals with NIDDM, FEBS Letters 368:225 (1995).